GL1X · GenesisL1 explorer

Ligand · CBT

CBT · N,N-bis(4-chlorobenzyl)-1H-1,2,3,4-tetraazol-5-amine

CBT, N,N-bis(4-chlorobenzyl)-1H-1,2,3,4-tetraazol-5-amine (C15 H13 Cl2 N5, 334.2 g/mol), in the MolNFT structures on GenesisL1: bound in 2 records (1 PDB entry). Every binding site with its residues within 4.5 Å, the residues it binds most…

Component
CBT
Formula
C15 H13 Cl2 N5
Class
ligand
Structures
2
PDB entries
1

Binding sites

CBT in 2 structures; the first of them:

  • 1PZO · TEM-1 Beta-Lactamase in Complex with a Novel, Core-Disrupting, Allosteric Inhibitor · CBT A300 · binds VAL216, ALA217, LEU220, SER235, GLY236, ALA237, ARG244, GLY245 and 4 more
  • 1PZO · Tem-1 beta-lactamase in complex with a novel, core-disrupting, allosteric inhibitor · CBT A300 · binds VAL216, ALA217, LEU220, SER235, GLY236, ALA237, ARG244, GLY245 and 4 more

Residues it binds most

ILE 4, LEU 4, ALA 4, GLY 4, ARG 4, ASN 4, VAL 4, SER 2 (residue and the binding sites it lines).

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.